Cite
Gliomas: Genetic alterations, mechanisms of metastasis, recurrence, drug resistance, and recent trends in molecular therapeutic options
MLA
Siddarth, Kannan, et al. “Gliomas: Genetic Alterations, Mechanisms of Metastasis, Recurrence, Drug Resistance, and Recent Trends in Molecular Therapeutic Options.” Biochemical Pharmacology, vol. 201, July 2022, p. 115090. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....04c42f39cf3fcf15dadd967672a5cd1f&authtype=sso&custid=ns315887.
APA
Siddarth, K., Avaniyapuram Kannan, M., Sathyamoorthy, B., Arasambattu Kannan, M., & Ali S, A. (2022). Gliomas: Genetic alterations, mechanisms of metastasis, recurrence, drug resistance, and recent trends in molecular therapeutic options. Biochemical Pharmacology, 201, 115090.
Chicago
Siddarth, Kannan, Murugan Avaniyapuram Kannan, Balasubramanian Sathyamoorthy, Munirajan Arasambattu Kannan, and Alzahrani Ali S. 2022. “Gliomas: Genetic Alterations, Mechanisms of Metastasis, Recurrence, Drug Resistance, and Recent Trends in Molecular Therapeutic Options.” Biochemical Pharmacology 201 (July): 115090. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....04c42f39cf3fcf15dadd967672a5cd1f&authtype=sso&custid=ns315887.